Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario

被引：0
|
作者：
Campenni, A. [1 ]
Giovanella, L. [2 ]
Pignata, S. [1 ]
Mure, M. [1 ]
Siracusa, M. [1 ]
Cosentino, F. [1 ]
Sturiale, L. [1 ]
Coppolino, P. [1 ]
Ruggeri, M. [3 ]
Baldari, S. [1 ]
机构：
[1] Nucl Med Unit Messina, Messina, Italy
[2] Nucl Med & PET CT Ctr, Oncol Inst Southern Switzerland, Bellinzona, Switzerland
[3] Univ Messina, Dept Clin & Expt Med & Pharmacol, Sect Endocrinol, Messina, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
PW092
引用
收藏
页码：S325 / S326
页数：2
相关论文
共 50 条
  • [21] Quality of Life Survey Following Radioiodine Ablation in Patients with Differentiated Thyroid Cancer
    Nikoleta Gkatzia
    Angelos Papadopoulos
    Petros Kostagiolas
    Theodoros Karianos
    Sofia Saranti
    [J]. SN Comprehensive Clinical Medicine, 2021, 3 (1) : 158 - 165
  • [22] The efficacy of radioiodine remnant ablation for differentiated thyroid carcinoma patients with an incomplete thyroidectomy
    Fu, Hongliang
    Ma, Chao
    Li, Jianing
    Feng, Fang
    Wu, Shuqi
    Ye, Zhiyi
    Wang, Hui
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 60 (03): : 280 - 284
  • [23] Editorial: Patients with differentiated thyroid carcinoma benefit from radioiodine remnant ablation
    Haugen, BR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08): : 3665 - 3667
  • [24] Analysis of Critical Parameters for Radioiodine Remnant Ablation in Patients with Differentiated Thyroid Carcinoma
    Mika, A. Valkovic
    Nekic, J.
    Ivankovic, S. Grbac
    Valkovic, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S482 - S482
  • [25] Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma
    Long, Bin
    Li, Linfa
    Yao, Lifang
    Chen, Shoucong
    Yi, Heqing
    Ye, Xuemei
    Xu, Dong
    Wu, Peng
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (08) : 244 - 247
  • [26] Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone
    Berg, G
    Lindstedt, G
    Suurküla, M
    Jansson, S
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (01) : 44 - 52
  • [27] Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone
    G. Berg
    G. Lindstedt
    M. Suurküla
    S. Jansson
    [J]. Journal of Endocrinological Investigation, 2002, 25 : 44 - 52
  • [28] Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
    Pitoia, Fabian
    Marlowe, Robert J.
    Abelleira, Erika
    Faure, Eduardo N.
    Bueno, Fernanda
    Schwarzstein, Diego
    Julio Lutfi, Ruben
    Niepomniszcze, Hugo
    [J]. JOURNAL OF THYROID RESEARCH, 2012, 2012
  • [29] Treatment strategy by radioiodine refractory differentiated thyroid cancer
    Mantsopoulos, Konstantinos
    Mueller, Sarina K.
    Pavel, Marianne
    Kuwert, Torsten
    Meidenbauer, Norbert
    Fietkau, Rainer
    Sievert, Matti
    Iro, Heinrich
    [J]. LARYNGO-RHINO-OTOLOGIE, 2022, 101 (04) : 298 - 303
  • [30] Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis
    Fu, H.
    Ma, C.
    Tang, L.
    Wu, F.
    Liu, B.
    Wang, H.
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 59 (01): : 121 - 128
12345